1. Home
  2. HTZ vs TSHA Comparison

HTZ vs TSHA Comparison

Compare HTZ & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hertz Global Holdings Inc

HTZ

Hertz Global Holdings Inc

HOLD

Current Price

$6.13

Market Cap

1.6B

ML Signal

HOLD

Logo Taysha Gene Therapies Inc.

TSHA

Taysha Gene Therapies Inc.

HOLD

Current Price

$6.69

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HTZ
TSHA
Founded
1918
2019
Country
United States
United States
Employees
26000
N/A
Industry
Rental/Leasing Companies
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.8B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
HTZ
TSHA
Price
$6.13
$6.69
Analyst Decision
Hold
Strong Buy
Analyst Count
3
8
Target Price
$5.67
$11.63
AVG Volume (30 Days)
15.3M
2.6M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
5.56
EPS
N/A
N/A
Revenue
N/A
$9,773,000.00
Revenue This Year
$4.94
N/A
Revenue Next Year
$3.62
$1,152.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
17.28
52 Week Low
$3.78
$2.07
52 Week High
$8.44
$7.30

Technical Indicators

Market Signals
Indicator
HTZ
TSHA
Relative Strength Index (RSI) 51.91 64.49
Support Level $4.98 $4.39
Resistance Level $7.24 $6.76
Average True Range (ATR) 0.63 0.43
MACD -0.08 0.02
Stochastic Oscillator 26.51 50.40

Price Performance

Historical Comparison
HTZ
TSHA

About HTZ Hertz Global Holdings Inc

Hertz Global Holdings Inc is engaged principally in the business of renting vehicles through its Hertz, Dollar and Thrifty brands. The company has two reportable segments: i) Americas RAC: Rental of vehicles, as well as sales of vehicles and value-added services, in the U.S., Canada, Latin America and the Caribbean, ii) International RAC: Rental of vehicles, as well as sales of vehicles and value-added services, in locations other than the U.S., Canada, Latin America and the Caribbean. The company maintains a substantial network of company-operated rental locations, a majority of which are in Europe, and has franchisees and partners that operate rental locations under brands. Geographical markets include North America, Europe, Pacific Asia, Middle East and Africa, and Latin America.

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a clinical-stage biotechnology company focused on advancing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system, or CNS. The company's clinical program TSHA-102 is in development for the treatment of Rett syndrome, a rare neurodevelopmental disorder with no approved disease-modifying therapies that address the genetic root cause of the disease. The Company views its operations and manages its business as a single operating segment, the gene therapy segment, which is the business of developing AAV-based gene therapies for the treatment of rare monogenic diseases of the central nervous system.

Share on Social Networks: